In fact, all tumor types listed in The Cancer Genome Atlas were found to have upregulated levels of P2RX7 expression, with sub-type-specific mutation patterns highlighting the significant potential for novel therapeutic approaches in this area (Young et al., 2017). Here, P2RX7 is linked to neoplasm.